All Funding Schemes

• Call open

  HRB Rapid Response Mechanism to support Ukrainian researchers in crisis 2022 (Ucrisis 2022)

  The aim of this supplemental funding scheme is to support displaced health-related researchers and technical staff from Ukraine to join active HRB-funded awards in order to integrate swiftly into the Irish research system, enable continuity in their research work and sustain the individuals’ research career and development.

• Call open

  Fulbright-HRB Health Impact Awards 2023

  Research and/or professional development (between three and six months) in the United States of America (USA).

• Call open

  Secondary Data Analysis Projects (SDAP 2023)

  Research projects employing secondary data analysis that supports policy and practice decision making for health and social care.

• US-Ireland Research and Development Partnership Programme

  Increasing collaboration between United States of America (USA), Republic of Ireland and Northern Ireland researchers

• National Clinical Trials Coordination Programme 2020

  The focus of the call is to support a national clinical trials coordination programme that is aligned to the local supports of the existing clinical trials infrastructures to ensure a harmonised strategic national approach to the conduct of high quality multicentre clinical trials in Ireland.

• HRB Postdoctoral Fellowships - Applying Research into Policy and Practice (ARPP) 2020 (Next call expected in January 2023)

  Fellowships in applied health research

• HRB Postdoctoral Internship Programme 2021-2022 Round 2 (Next call expected in Q4 2023)

  Internship awards for postdoctoral fellows: First-hand experience of working in a State agency alongside experienced professionals.

• Summer Student Scholarships (SS) 2022 (Next call TBC)

  Short research projects for undergraduate students in a health or social care-related discipline

• Research visits – Ulysses 2022

  Travel awards for exchange visits to French researchers

• NCI Summer Curriculum in Cancer Prevention (TBC)

  To respond to evolving training needs in the area of cancer prevention, the NCI has confirmed this course will be “under construction” until further notice, with the expectation of updating aspects of the design, content, learning objectives, and delivery modes for diverse audiences. Please check back with CPFP’s website https://cpfp.cancer.gov/summer-curriculum , for updates about future NCI trainings and other existing resources.” Support to attend one or two courses on offer at the National Cancer Institute

• Emerging Investigator Awards for Health (EIA) 2022 (Next call expected in 2024)

  Supporting new independent investigators who can facilitate actionable knowledge in health research

• HRB Impact Award 2023

  The award will recognise a HRB-funded researcher who has led their research to impact/s on policy, practice, services or the health and social care system.

• Research Leader Awards (RL) 2020 (Next call TBC)

  Supporting established health investigators in academic setting transitioning to leadership in health research.

• Emerging Clinician Scientist Awards (ECSA) 2020 (Next call expected in 2023)

  Supporting health and care practitioners currently at mid-stage of their research career transitioning to research independence.

• HRB Postdoctoral Fellowships - Clinician Scientist Postdoctoral Fellowships (CSF) 2020 (Next call expected in January 2023)

  Fellowships for Health and Care Practitioners in applied health research.

• HRB Clinical Research Facilities/Centres (CRF/C) 2021 (Next call TBC)

  The overarching aim of the HRB Clinical Research Facilities/Centres call is to support/upgrade national CRF/Cs to international standing, increase accessibility to trials for patients and healthy volunteers, and improve the supports available to investigators to drive an increase in investigator-led clinical trials.

• Cancer trials in Ireland 2021

  The overall goal of the new funding model for HRBs investment in cancer trials in Ireland is to support an appropriate infrastructure; enabling Irish patients to access a diverse portfolio of high-quality, safe and compliant cancer clinical trials in Ireland.

• Investigator-Led Projects (ILP) 2022 (Next call TBC)

  Projects in (i) Patient-oriented research (POR), (ii) Population health research (PHR), and (iii) Health services research (HSR).

• HRCI-HRB Joint Funding Scheme 2022 (previously MRCG-HRB) (Next call TBC)

  HRCI/HRB Joint Funding Scheme aims to fund researchers and research teams to conduct internationally competitive and innovative research in areas of strategic relevance to each individual charity.

• DOROTHY Co-Fund Programme: Postdoctoral Fellowships in Public Health Crisis - (Next call in Q4 2022)

  Postdoctoral fellowships training future experts who can tackle public health crisis.

• ERA PerMed Joint Transnational Call (2022): “Prevention in Personalised Medicine”

  ERAPerMed have launched the fifth Joint Transnational Call for international high-quality research projects to foster research on prevention in Personalised Medicine (PM).

• European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (2022): “Development of new analytic tools and pathways to accelerate diagnosis and facilitate diagnostic monitoring of rare diseases”

  International collaboration on Rare Disease Research with expected impact to use the results in future for benefit of patients.

• Conference and Event Sponsorship Scheme 2022 (CES 2022)

  The Conference and Events Sponsorship Scheme aims to create an opportunity to host health research related events, workshops, or conferences in Ireland.

• Joint Programming Initiative “A Healthy Diet for a Healthy Life’ (JPI HDHL) Call 2022 (NUTRIMMUNE)

  Joint Transnational Call “Nutrition-responsiveness of the immune system: interplay between infectious diseases and diet-related metabolic diseases and the potential for food-based solutions (NUTRIMMUNE)”.

• Definitive Intervention and Feasibility Awards (DIFA) 2023 - Full Application

  The overarching aim of the Definitive Interventions and Feasibility Awards (DIFA) is to deliver tangible benefits to patients, peoples’ health and health services through the support of studies evaluating a full scale, definitive intervention of any appropriate design to provide high-quality evidence on the efficacy, effectiveness, cost and broad impact of the intervention. To achieve a pipeline of such studies, both definitive interventions and feasibility studies conducted in preparation for future definitive intervention, are supported. The DIFA scheme also supports the conduct of trial methodology research (SWATs) within the context of proposed interventions.

• ERA-Net JPIAMR-ACTION Transnational Network Call (2022)

  The aim of the call is to assemble networks of experts and stakeholders with the goal of facilitating the development, optimisation and use of diagnostic and surveillance tools, technologies, and systems to reduce the burden of antimicrobial resistance (AMR).

• Knowledge Translation Awards (KTA) 2022

  The aim of this scheme is to provide HRB funded researchers with an opportunity to seek supplementary funding for knowledge translation activities not covered in the original award that will maximise the potential impact of the research findings on policy or practice or communicate research and research findings to the general public.

• Collaborative Doctoral Awards in Patient-focused Research (CDA) 2021 (next call expected in 2023)

  Supporting excellent doctoral training programmes for future health researchers in the conduct of patient-focused research.

• Secondary Data Analysis Projects (SDAP 2021) - (Next Call October 2022)

  Update: The HRB Secondary Data Analysis Projects (SDAP) 2021 call is currently open. The deadline for submission was extended by one week to consider the implications of recent cyberattacks on HSE and related systems. We wish to confirm that the call deadline remains as 13:00 Friday 4th June, and applicants should plan on this basis. We appreciate and regret the fact that a small number of applicant teams may not make this deadline due to the direct and indirect impacts of the cyberattack and we can confirm that there will be further rounds of SDAP that will issue as part of the HRB Strategy (2021-2025). Lead applicants and Host Institutions are being informed of this confirmed deadline. Research projects employing secondary data analysis that supports policy and practice decision making for health and social care.

• ERA-NET-Cofund TRANSCAN-3 Joint Transnational Call (2022) “Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy”

  The expected impact of the call is to improve the efficacy of current diagnosis, prognosis and treatment of hard-to-treat cancers (HTTCs) through the development of novel personalized approaches based on a better understanding of the peculiarities of HTTC.